| |
| |
|
| Insider
Information: |
Mcgrath John |
| Relationship: |
EVP & Chief Financial ... |
| City: |
Fremont |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
108,631 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$61,246 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
108,631 |
|
|
| Total
Value |
$61,246 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Endwave Corp |
ENWV |
Director |
2005-07-29 |
0 |
2005-07-29 |
0 |
Premium* |
|
|
Network Equipment Technologies Inc |
NWK |
EXC.112.VP CFO |
2009-11-05 |
19,869 |
2006-05-05 |
0 |
Premium* |
|
|
Atara Biotherapeutics, Inc. |
ATRA |
EVP & Chief Financial ... |
2018-03-20 |
88,762 |
2015-01-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Financial Officer |
• – – |
2018-03-20 |
4 |
AS |
$38.83 |
$116,490 |
D/D |
(3,000) |
88,762 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Financial Officer |
• – – |
2018-03-19 |
4 |
AS |
$41.99 |
$125,970 |
D/D |
(3,000) |
91,762 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Financial Officer |
• – – |
2018-02-16 |
4 |
AS |
$46.93 |
$307,920 |
D/D |
(6,500) |
94,762 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Financial Officer |
• – – |
2018-02-15 |
4 |
AS |
$46.77 |
$304,005 |
D/D |
(6,500) |
99,056 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Financial Officer |
• – – |
2018-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,132 |
104,188 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Financial Officer |
• – – |
2018-02-15 |
4 |
D |
$47.05 |
$137,668 |
D/D |
(2,926) |
101,262 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Financial Officer |
• – – |
2018-02-09 |
4 |
D |
$41.70 |
$200,952 |
D/D |
(4,819) |
105,556 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Financial Officer |
• – – |
2018-02-06 |
4 |
D |
$35.80 |
$153,188 |
D/D |
(4,279) |
110,375 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Financial Officer |
• – – |
2018-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
114,654 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Financial Officer |
• – – |
2018-01-12 |
4 |
OE |
$11.00 |
$330,000 |
D/D |
30,000 |
123,154 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Financial Officer |
• – – |
2018-01-12 |
4 |
AS |
$22.32 |
$828,120 |
D/D |
(33,500) |
89,654 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Financial Officer |
• – – |
2018-01-11 |
4 |
AS |
$20.77 |
$72,695 |
D/D |
(3,500) |
93,154 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Financial Officer |
• – – |
2017-12-29 |
4 |
AS |
$20.00 |
$640,000 |
D/D |
(32,000) |
96,654 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Financial Officer |
• – – |
2017-11-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,697 |
128,654 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Financial Officer |
• – – |
2017-08-16 |
4 |
AS |
$14.39 |
$30,219 |
D/D |
(2,100) |
120,957 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Financial Officer |
• – – |
2017-08-15 |
4 |
AS |
$14.23 |
$29,883 |
D/D |
(2,100) |
123,057 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Financial Officer |
• – – |
2017-08-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,697 |
125,157 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Financial Officer |
• – – |
2017-05-16 |
4 |
AS |
$15.27 |
$30,540 |
D/D |
(2,000) |
117,460 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Financial Officer |
• – – |
2017-05-15 |
4 |
AS |
$14.95 |
$29,900 |
D/D |
(2,000) |
119,460 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Financial Officer |
• – – |
2017-05-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,633 |
121,460 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Financial Officer |
• – – |
2017-03-23 |
4 |
AS |
$21.08 |
$137,020 |
D/D |
(6,500) |
112,827 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Financial Officer |
• – – |
2017-03-22 |
4 |
AS |
$20.27 |
$152,025 |
D/D |
(7,500) |
119,327 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Financial Officer |
• – – |
2017-03-10 |
4 |
AS |
$20.00 |
$480,000 |
D/D |
(24,000) |
126,827 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Financial Officer |
• – – |
2017-02-21 |
4 |
AS |
$15.14 |
$136,260 |
D/D |
(9,000) |
150,827 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief Financial Officer |
• – – |
2017-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,501 |
159,827 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
